Oracle Investment Management Inc. reduced its holdings in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Free Report) by 3.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 535,558 shares of the biotechnology company’s stock after selling 19,964 shares during the period. […]
BioCryst Pharmaceuticals, Inc (NASDAQ:BCRX) Director Buys $49,995 96 in Stock modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.